Recognizing World Cancer Day & National Cancer Prevention Month
Every cancer journey is unique—shaped by the individual, the disease, and the evolving landscape of treatment.
ASH 2024 Highlights
ASH 2024 Highlights:
Advancing Therapeutic Scalability, Precision Medicine, and Next-Gen Trial Designs
Oncology Breakthroughs – ESMO Congress 2024
Upon their return from ESMO Congress 2024 and in recognition of World Cancer Research Day, Medpace oncology experts identified three...
Oncology Breakthroughs – ASCO 2024 Highlights
Explore insights from Medpace oncology experts as they identify several of the latest innovations in hematologic and oncologic research shared at ASCO 2024.
Medpace Expands Oncology Medical Leadership Team
Medpace is pleased to announce the addition of new Oncology expert, Dr. Amanda Goldrick, to the Medical Leadership team.
Emerging Trends in Hematology – ASH 2023 Highlights
In December 2023, Medpace classic and malignant hematology experts attended the 65th American Hematology Society (ASH) conference in San Diego, CA. Learn more from Blythe…
[On-Demand Webinar] Liquid Biopsy in Oncology: Opportunities and Challenges
Join featured speakers from Medpace on September 8th, as they provide an overview of the current methodologies involved in liquid biopsies and their application for…
Blythe Thomson, MD, Rejoins Medpace Bringing New Experiences and Insights from a Sponsor’s Perspective
Medpace is pleased to announce that Dr. Blythe Thomson has rejoined Medpace’s Hematology and Oncology medical leadership team after spending several years holding a variety…
Infectious Diseases in the Immunocompromised Host
An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.
Medpace’s Focus on Hematology and Oncology Aligns with Innovative Biotechs
Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development